insights_auto
Nega BMRN tushdi 2,73%?
Batafsil oʻrganishchevron_right
BMRN:NASDAQ
Biomarin Pharmaceutical Inc
55,97Â US$
arrow_downward
-2,73%(-1,57) 1K
6-okt, 15:37:23 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoBMRN tikeri uchun statistika yaratilmoqda...
Ochish
57,54Â US$
Yuqori
57,88Â US$
Past
55,76Â US$
Bozor kapitali
10,77Â mlrd
Oʻrtacha hajm
1,96Â mln
Hajmi
1,93Â mln
P/E koeffitsiyenti
150,89
52 haftalik eng yuqori
70,98Â US$
52 haftalik eng past
49,26Â US$
Aksiya boʻyicha daromad
0,37Â US$
Beta
0,22
Muomaladagi aksiyalar
193,57Â mln
Xodimlar soni
3Â ming
Ochish
57,54Â US$
Yuqori
57,88Â US$
Past
55,76Â US$
Bozor kapitali
10,77Â mlrd
Oʻrtacha hajm
1,96Â mln
Hajmi
1,93Â mln
P/E koeffitsiyenti
150,89
52 haftalik eng yuqori
70,98Â US$
52 haftalik eng past
49,26Â US$
Aksiya boʻyicha daromad
0,37Â US$
Beta
0,22
Muomaladagi aksiyalar
193,57Â mln
Xodimlar soni
3Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
PR Newswire
·
23 soat oldin
BioMarin Appoints Cara Bauer as Chief People Officer
Profil
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria.
Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
Biomarin Pharmaceutical Inc haqida
CEOAlexander Hardy
Xodimlar soni3,22Â ming
Asos solinganmar 1997
Bosh ofislarSan Rafael, Kaliforniya, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytbiomarin.com